Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 844-324-4673
Summary
- Dr. Justin Taylor is an oncologist and physician-scientist in Miami, FL and is affiliated with the Sylvester Comprehensive Cancer Center. He received his medical degree from the University of New Mexico School of Medicine, completed Internal Medicine training at the Brigham and Women’s Hospital and Hematology/Oncology fellowship at Memorial Sloan Kettering Cancer Center and has been in practice for 6 years. He specializes in hematologic oncology.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2011 - 2014
University of New Mexico School of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2020 - 2026
NY State Medical License 2014 - 2022
MA State Medical License 2011 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 156 citationsSomatic mutations and cell identity linked by Genotyping of TranscriptomesAnna S. Nam, Kyu-Tae Kim, Ronan Chaligne, Franco Izzo, Chelston Ang
Nature. 2019-07-01 - 65 citationsDiagnosis and Treatment of Myelodysplastic Syndromes: A Review.Mikkael A Sekeres, Justin Taylor
JAMA. 2022-09-06 - 350 citationsH3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.Michael Seiler, Akihide Yoshimi, Rachel Darman, Betty Chan, Keaney Gregg F
Nature Medicine. 2018-02-19
Abstracts/Posters
- Aberrant RNA Splicing Contributes to the Pathogenesis of EVI-Rearranged Myeloid LeukemiasJustin Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction ChemotherapyJustin Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant LeukemiasJustin Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024- Sylvester Pursues Landmark Research Presented at International Hematology ConferenceJanuary 30th, 2023
- Ask the Experts: The Potential of Tyrosine Kinase Inhibitors in OncologyApril 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
